AzTrials
AzTrials

Suicide PreventionNCT06782516

Native-RISE (Risk Identification for Suicide and Enhanced Care)

A study testing System of Care - combination of algorithm and Brief Contact Intervention and Active Comparator - Provider notification of risk status in people with Suicide Prevention, run by Johns Hopkins Bloomberg School of Public Health at 3 sites in United States.

Enrolling by invitation

Enrolling by invitation. The study team selects and invites participants, usually from an existing group of patients.

Sites and contacts
Official record
Search all trials

Trial summary

The goal of this research is to test a systems-level suicide prevention strategy, Native-RISE (Risk Identification for Suicide and Enhanced care), that combines predictive analytics and brief contact interventions (BCIs) to reduce suicide in health systems serving Native Americans (NAs). Read more about this study

Who is it for?
Ages 18 to 75 years
Conditions the study is for
Suicide Prevention
What is being tested?
System of Care - combination of algorithm and Brief Contact Intervention and Active Comparator - Provider notification of risk status
Could I receive a placebo?
No, everyone receives an active treatment
How many people
1,687 participants
Where
3 sitesUnited States
Study dates
1 Dec 2024to 31 Dec 2028
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 75 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Adults aged 18-75
  • Visit at least one of the three participating IHS clinics
  • Identified as at risk of suicide by either an existing method or the new Native-RISE risk model algorithm

Who cannot join

  • None

Trial locations and contacts

3 sites in 1 country. Contact the study team or a site near you to ask about taking part.

United States3 sites
  • Chinle Navajo Nation Center for Indigenous Health

    Chinle, Arizona, 86503

  • Shiprock Center for Indigenous Health

    Shiprock, New Mexico, 87420

  • Whiteriver Center for Indigenous Health

    Whiteriver, Arizona, 85941

Other trials in United States

About this study

The goal of this research is to test a systems-level suicide prevention strategy, Native-RISE (Risk Identification for Suicide and Enhanced care), that combines predictive analytics and brief contact interventions (BCIs) to reduce suicide in health systems serving Native Americans (NAs). This project aims to prove the effectiveness and scalability of Native-RISE within three Indian Health Service (IHS) health care clinics (Whiteriver, Chinle and Shiprock) already implementing suicide prevention programs and serving the White Mountain Apache Tribe (WMAT) and Navajo Nation (NN).

Being tested
System of Care - combination of algorithm and Brief Contact Intervention, Active Comparator - Provider notification of risk status
Medical subject headings
Suicide Prevention

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • System of Care - combination of algorithm and Brief Contact InterventionDevice

    Case managers see the Native-RISE algorithm classification and Clinical Providers receive a risk notification. A resource card is provided to the participant.

  • Active Comparator - Provider notification of risk statusBehavioural

    Clinical Providers receive a risk notification and a resource card is provided to the participant.

Study groups in NCT06782516
Study groupRoleWhat they receive
Case Managers WITH algorithm AND with provider risk notification (SI/SA/Binge/NSSI)ExperimentalCase Managers who see the algorithm classification + IHS provider risk notification \& resource card distribution. These participants present with suicide ideation (SI), suicide attempt (SA), binge substance use (Binge), or non-suicidal self injury (NSSI).
Receives: Device: System of Care - combination of algorithm and Brief Contact Intervention
Case Managers withOUT algorithm AND with provider risk notification (SI/SA/Binge/NSSI)Active comparatorCase Managers who do NOT see the algorithm classification + IHS provider risk notification \& resource card distribution. These participants present with suicide ideation (SI), suicide attempt (SA), binge substance use (Binge), or non-suicidal self injury (NSSI).
Receives: Behavioral: Active Comparator - Provider notification of risk status
Case Managers WITH algorithm AND provider risk notification (high risk history, no SI/SA/Binge/NSSIExperimentalCase Managers who see the algorithm classification + provider risk notification; participants get resource card distribution. High risk participants based on algorithm classification.
Receives: Device: System of Care - combination of algorithm and Brief Contact Intervention
Provider risk notification alone (high risk history, without SI/SA/Binge/NSSI)Active comparatorProvider risk notification alone; participants get resource card distribution. High risk participants based on algorithm classification.
Receives: Behavioral: Active Comparator - Provider notification of risk status

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Rate of suicide attempts among individuals flagged at elevated risk

    Rate of suicide attempts among individuals flagged at elevated risk is tracked through International Classification of Diseases (ICD) codes and chief complaints as recorded in the participating health system.

    Measured: 12 months

Secondary outcomes (1)
  1. Number of contacts with Case Managers (Reach of Brief Contact Interventions (BCI))

    Reach of BCI is defined as at least three or more contacts with Case Managers within the first year following identification of elevated risk.

    Measured: 12 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted20 Jan 2025
  2. Study start1 Dec 2024
  3. Primary completion30 Sep 2028 (estimated)
  4. Study completion31 Dec 2028 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Health services research
Allocation
Randomised
Intervention model
Parallel groups
Model description
Native-RISE Model is a predictive algorithm for suicide risk in Native American populations. The algorithm was developed based on analysis of over 330,000 visits and designed to identify people at risk of a suicide attempt or death within 90 days of the last visit. The evaluation of the model initial results have been published with the model having an area under the ROC (AUROC) 0.83 \[0.80-0.86\]) and performing better than existing care (AUROC 0.64 \[0.61-0.67\]).
Masking
Single blind
Who is masked
Care provider
Enrolment
1,687 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06782516
Sponsor's protocol ID
IRB00026145
Status last verified
Jan 2026
First submitted
15 Jan 2025
Last updated
2 Feb 2026
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Haroz EE, Rebman P, Goklish N, Garcia M, Suttle R, Maggio D, Clattenburg E, Mega J, Adams R. Performance of Machine Learning Suicide Risk Models in an American Indian Population. JAMA Netw Open. 2024 Oct 1;7(10):e2439269. doi: 10.1001/jamanetworkopen.2024.39269.

    PubMed 39401036
  • Adams R, Haroz EE, Rebman P, Suttle R, Grosvenor L, Bajaj M, Dayal RR, Maggio D, Kettering CL, Goklish N. Developing a suicide risk model for use in the Indian Health Service. Npj Ment Health Res. 2024 Oct 16;3(1):47. doi: 10.1038/s44184-024-00088-5.

    PubMed 39414996

Questions about this trial

What is this clinical trial studying?

A study testing System of Care - combination of algorithm and Brief Contact Intervention and Active Comparator - Provider notification of risk status in people with Suicide Prevention, run by Johns Hopkins Bloomberg School of Public Health at 3 sites in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: enrolling by invitation, as of the sponsor's last update on 2 Feb 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 3 sites in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Rate of suicide attempts among individuals flagged at elevated risk (time frame: 12 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06782516, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 2 Feb 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in